Equistone Partners has agreed to acquire a majority stake in Omnicare, a pharmaceutical wholesaler operating throughout Germany, that primarily distributes finished medicinal products to compounding pharmacies for the patient-specific production of cancer drugs. Financial terms were not disclosed. “Omnicare is a market leader with an experienced management team and excellent employees. These are strong foundations to help secure the company’s further development. As a new shareholder, Equistone will support Omnicare in strengthening and sustainably consolidating its market position,” Alexis Milkovic, Equistone Partner.